Australian Investor
home page boresight
WDS$29.92
-3.30%
TLS$5.17
+0.98%
STO$8.45
-4.20%
PLS$2.62
-8.39%
FMG$13.44
-9.49%
CBA$169.92
-0.56%
CSL$197.29
-2.77%
BHP$51.40
-12.67%
SQ2$95.20
-0.55%
WDS$29.92
-3.30%
TLS$5.17
+0.98%
STO$8.45
-4.20%
PLS$2.62
-8.39%
FMG$13.44
-9.49%
CBA$169.92
-0.56%
CSL$197.29
-2.77%
BHP$51.40
-12.67%
SQ2$95.20
-0.55%
Back to Articles
fundraising
NUZ
Offer Open

Neurizon Therapeutics Strengthens Capital with $6.3M Raise

Neurizon Therapeutics has raised $4.3 million through a placement and launched a $2 million share purchase plan.

November 6, 2026
Share:
Neurizon Therapeutics Strengthens Capital with $6.3M Raise

Neurizon Therapeutics (ASX: NUZ) has successfully raised $4.3 million via a placement of 63.2 million shares at $0.068 per share. The company has also launched a $2 million share purchase plan to simplify its capital structure and fund the continued development of its NUZ-001 clinical program through mid-2027.

Capital Raise
Biotech
ASX